Medicine and Dentistry
Recombinant Blood Clotting Factor 8
59%
Patient
53%
Complication
46%
Assay
36%
Von Willebrand Factor
29%
Von Willebrand Factor Cleaving Proteinase
29%
Rehabilitation Engineering
25%
Child
25%
Liver
25%
Gut
25%
Chronic Liver Disease
25%
In Vitro
22%
Light-Scattering Spectroscopy
20%
Measles
20%
Pharmacodynamics
20%
Haemophilia A
20%
Photon Correlation Spectroscopy
20%
High-Performance Liquid Chromatography
20%
Polycythemia vera
19%
Analysis
19%
Combination Therapy
15%
Development
15%
Edoxaban
15%
Percutaneous Endoscopic Gastrostomy
15%
C Reactive Protein
15%
Age
11%
Therapeutic Procedure
10%
Absence
10%
Blood Clotting Factor 8 Concentrate
10%
Glycosylation
10%
Immunogenicity
10%
Pharmaceutical Formulation
10%
Aptitude
10%
Cell Line
10%
Genotype
10%
Measurement
9%
Antigen
9%
Essential Thrombocythaemia
9%
Exercise
8%
Frail Elderly
8%
Adjustment
8%
Clinical Trial
8%
Blood Clotting Factor 8
8%
Accuracy
7%
Atrial Fibrillation
7%
Janus Kinase
6%
Retrospective Study
5%
Follow up
5%
Sequela
5%
Encephalitis
5%
Biochemistry, Genetics and Molecular Biology
Von Willebrand Factor
100%
Von Willebrand Factor
51%
ADAMTS
47%
Hemoglobin
25%
Pharmacodynamics
22%
High-Performance Liquid Chromatography
20%
Dynamic Light Scattering
20%
Haemophilia A
20%
Light-Scattering Spectroscopy
20%
Mutation
19%
Development
16%
Molecule
16%
Clinical Trial
15%
Conformation
15%
Force
14%
Phenotype
12%
Factor VIII
11%
Blood Level
11%
Conformational Change
11%
Platelet
11%
Glycosylation
10%
Immunogenicity
10%
Coagulation Factor VIII
10%
Aptitude
10%
Essential Thrombocythaemia
9%
Normal Human
8%
Protein
7%
Scavenger Receptor
7%
Von Willebrand Disease
6%
Circulation
6%
Secretion (Process)
6%
Observational Study
6%
Tension
6%
Thrombophilia
6%
Flow Rate
6%
Prevalence
6%
Doppler Ultrasonography
6%
Prospective Study
6%
Ristocetin
6%
Molecular Weight
5%
Lipoprotein Receptor-Related Protein
5%
Nursing and Health Professions
Patient
25%
Von Willebrand Factor
19%
Polycythemia vera
19%
Edoxaban
15%
Percutaneous Endoscopic Gastrostomy
15%
Inpatient
13%
Antigen
9%
Thrombocythemia
9%
Atrial Fibrillation
7%
Blood Clotting Factor 8
6%
Pilot Study
5%
Thromboembolism
5%
Anticoagulation
5%
Anticoagulant Agent
5%
Follow up
5%
Blood Level
5%
Combination Therapy
5%
Dose
5%
